These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3153436)

  • 1. Cutaneous expression of graft-v-host disease in man.
    Mauduit G; Claudy A
    Semin Dermatol; 1988 Jun; 7(2):149-55. PubMed ID: 3153436
    [No Abstract]   [Full Text] [Related]  

  • 2. [Graft-versus-host disease: a dermatologic view of an interdisciplinary problem].
    Rupec RA; Plewig G
    J Dtsch Dermatol Ges; 2004 Apr; 2(4):249-59. PubMed ID: 16285321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous graft-versus-host disease: rationales and treatment options.
    Chavan R; el-Azhary R
    Dermatol Ther; 2011; 24(2):219-28. PubMed ID: 21410611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous manifestations of graft-versus-host disease: role of the dermatologist.
    Kavand S; Lehman JS; Hashmi S; Gibson LE; El-Azhary RA
    Int J Dermatol; 2017 Feb; 56(2):131-140. PubMed ID: 27658806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
    Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
    Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of overlap cutaneous graft-versus-host disease with combination therapy of extracorporeal photopheresis and alemtuzumab.
    Oh CC; Lee HY; Chan MF; Gopalakrishnan SK
    Int J Dermatol; 2016 Mar; 55(3):335-8. PubMed ID: 25209118
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous manifestations of chronic graft-versus-host disease.
    Andrews ML; Robertson I; Weedon D
    Australas J Dermatol; 1997 May; 38(2):53-62; quiz 63-4. PubMed ID: 9159958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exanthema and enanthema in graft versus host disease (GVHD).
    Suzuki M; Kikkawa Y; Hasegawa T; Kaneko F
    Fukushima J Med Sci; 1993 Dec; 39(2):101-7. PubMed ID: 7927132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A call for more dermatologic input into chronic graft-vs-host disease clinical trials.
    Cowen EW
    Arch Dermatol; 2009 Mar; 145(3):337-8. PubMed ID: 19289778
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mucocutaneous and salivary manifestations of the graft vs host reaction after bone marrow transplantation].
    d'Agay MF; Brocheriou C; Kuffer R; Gluckman E; Janin A; Saurat JH
    Rev Stomatol Chir Maxillofac; 1984; 85(5):370-4. PubMed ID: 6393313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing face of graft-versus-host disease.
    Schaffer JV
    Semin Cutan Med Surg; 2006 Dec; 25(4):190-200. PubMed ID: 17174839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging dermatologic issues in the oncology patient.
    Mays SR; Cohen PR
    Semin Cutan Med Surg; 2006 Dec; 25(4):179-89. PubMed ID: 17174838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation.
    Takatsuka H; Takemoto Y; Yamada S; Mori A; Wada H; Fujimori Y; Okamoto T; Kanamaru A; Kakishita E
    Hematology; 2002 Feb; 7(1):55-7. PubMed ID: 12171778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous manifestations of graft versus host disease (author's transl)].
    Sohier J; Janin-Mercier A; Saurat JH; Devergie A; Gluckman E
    Bull Cancer; 1981; 68(1):78-80. PubMed ID: 7225608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous chronic graft-versus-host disease localized to the field of total lymphoid irradiation.
    Okamoto S; Takahashi S; Inoue T; Tojo A; Tani K; Kikuchi A; Shimizu H; Nishikawa T; Ikeda Y; Asano S
    Bone Marrow Transplant; 1996 Jan; 17(1):111-3. PubMed ID: 8673042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous manifestations of systemic disease: sarcoidosis, GVHD, Behcet's disease, and pyoderma gangrenosum.
    McCann SA
    Dermatol Nurs; 2007 Feb; 19(1):75-7. PubMed ID: 17330557
    [No Abstract]   [Full Text] [Related]  

  • 17. Blockade of acute grade IV skin and eye graft-versus-host disease by anti-interleukin-2 receptor monoclonal antibody in genoidentical bone marrow transplantation setting.
    Ozşahin H; Tuchschmid P; Lauener R; Waldvogel K; Nadal D; Seger RA
    Turk J Pediatr; 1998; 40(2):231-5. PubMed ID: 9677728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute follicular graft-vs-host reaction. A distinct clinicopathologic presentation.
    Friedman KJ; LeBoit PE; Farmer ER
    Arch Dermatol; 1988 May; 124(5):688-91. PubMed ID: 3284466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of dermatologic complications of chronic graft versus host disease: a case study.
    DeMeyer ES; Fletcher MA; Buchsel PC
    Clin J Oncol Nurs; 1997 Oct; 1(4):95-104. PubMed ID: 9410658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.